[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31388]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12824]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Capricorn Pharma, Inc.

    By Notice dated March 8, 2012, and published in the Federal 
Register on March 20, 2012, 77 FR 16262, Capricorn Pharma, Inc., 6900 
English Muffin Way, Unit A, Frederick, Maryland 21703, made application 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of Fentanyl (9801), a basic class of controlled substance 
listed in schedule II.
    The company plans to import the listed controlled substance in 
finished dosage form (FDF) from foreign sources for analytical testing 
and clinical trials in which the foreign FDF will be compared to the 
company's own domestically manufactured FDF. This analysis is required 
to allow the company to export domestically manufactured FDF to foreign 
markets.
    In reference to the import of Fentanyl (9801), the authorization 
for the import of this basic class of controlled substance is granted 
only for analytical testing and clinical trials. This authorization 
does not extend to the import of a finished FDA approved or non-
approved dosage form for commercial distribution in the United States.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Capricorn Pharma, Inc., to import the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Capricorn 
Pharma, Inc., to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

     Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12824 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P